Akèy › Ipètansyon pulmonè
Etid klinik pou Ipètansyon pulmonè ap rekrite nan Etazini
55 etid pou Ipètansyon pulmonè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Philadelphia, PA10 etid
- Aurora, CO9 etid
- Phoenix, AZ9 etid
- Cincinnati, OH8 etid
- Indianapolis, IN8 etid
- New York City, NY8 etid
- Kansas City, KS8 etid
- Boston, MA8 etid
- Salt Lake City, UT7 etid
- Bend, OR7 etid
- Rochester, MN7 etid
- Charleston, SC7 etid
- Houston, TX7 etid
- Durham, NC6 etid
- Atlanta, GA6 etid
- Louisville, KY6 etid
- Los Angeles, CA6 etid
- Washington, DC5 etid
- Orlando, FL5 etid
- Rochester, NY5 etid
- Chicago, IL5 etid
- San Francisco, CA5 etid
- Providence, RI5 etid
- Pittsburgh, PA4 etid
- Richmond, VA4 etid
- Birmingham, AL4 etid
- Albuquerque, NM4 etid
- Portland, OR4 etid
- Cleveland, OH4 etid
- Sacramento, CA4 etid
- Tampa, FL4 etid
- Dallas, TX4 etid
- Denver, CO4 etid
- Minneapolis, MN4 etid
- Omaha, NE4 etid
- Ann Arbor, MI4 etid
- Nashville, TN4 etid
- Detroit, MI4 etid
- Oklahoma City, OK3 etid
- Milwaukee, WI3 etid
Pa eta
- Alabama4 etid
- Arizona10 etid
- Colorado12 etid
- Distrik Columbia4 etid
- Florid12 etid
- Georgia6 etid
- Illinois6 etid
- Indiana8 etid
- Kalifòni14 etid
- Kansas8 etid
- Kentucky7 etid
- Lwizyàn5 etid
- Maryland5 etid
- Massachusetts8 etid
- Michigan9 etid
- Minnesota8 etid
- Missouri5 etid
- Nebraska4 etid
- New Jersey4 etid
- New Mexico4 etid
- New York9 etid
- North Carolina8 etid
- Ohio12 etid
- Oklahoma4 etid
- Oregon10 etid
- Pennsylvania13 etid
- Rhode Island5 etid
- South Carolina9 etid
- Tennessee7 etid
- Texas7 etid
- Utah7 etid
- Virginia6 etid
- Wisconsin3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Oct 1, 2026 · NCT07214376Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07179380HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07123779Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT01730092Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07318597Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07837830Natural History of Sickle Cell Disease
Ap rekriteEtid obsèvasyon
Laj 2 a 90 · Tout sèks · Mizajou Sep 16, 2026 · NCT00081523A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 8, 2026 · NCT07473700Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07285655Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07132788DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Ap rekriteVolontè an sante akeyi
1 Month – 5 Months · Tout sèks · Mizajou Aug 26, 2026 · NCT06373289Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07136623Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05873387De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Ap rekriteFaz 4
0 Months – 1 Month · Tout sèks · Mizajou Aug 18, 2026 · NCT05213676Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
Ap rekriteFaz 4
28 Days · Tout sèks · Mizajou Aug 18, 2026 · NCT07322133Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Ap rekriteFaz 2
Laj 8 a 60 · Tout sèks · Mizajou Aug 14, 2026 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07234032Xenon MRI Pulm Hypertension
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 10, 2026 · NCT04991454A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Aug 10, 2026 · NCT07175038Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Jul 31, 2026 · NCT06770023The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07561034Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.